Navigation Links
Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2011 Results
Date:8/9/2011

11 from RMB53.7 million for the same period in 2010.  Sales of Endu constituted 12.8% of the Company's total revenue for the second quarter of 2011. For the first six months of 2011, revenue from Endu totaled RMB119.7 million (US$18.5 million), which represented an increase of 31.3% from RMB91.2 million for the same period in 2010.

Revenue from Sinofuan, a 5-FU sustained release implant for the treatment of cancer, increased by 25.8% to RMB53.0 million (US$8.2 million) for the second quarter of 2011 from RMB42.1 million for the same period in 2010.  Sales of Sinofuan constituted 9.7% of the Company's total revenue for the second quarter of 2011. For the first six months of 2011, revenue from Sinofuan totaled RMB82.4 million (US$12.7 million), which represented an increase of 22.0% from RMB67.5 million for the same period in 2010.

Revenue from other branded generic products including Zailin and Yingtaiqing decreased by 8.0% to RMB205.3million (US$31.7 million) from RMB223.1 million for the same period in 2010. Sales of other branded generic products constituted 37.6% of the Company's total revenue for the second quarter of 2011. For the first six months of 2011, revenue from other branded generic products totaled RMB419.7 million (US$64.9 million), which represented an increase of 0.4% from RMB418.1 million for the same period in 2010.

Gross margin for the second quarter of 2011 was 84.9%, compared to 86.8% for the same period in 2010. For the first six months of 2011, gross margin was 84.4%, compared to 83.5% in the first six months of 2010.

Research and development expenses for the second quarter of 2011 totaled RMB40.1 million (US$6.2 million), which represented an increase of 28.7% from RMB31.2 million for the same period in 2010. This increase was due primarily to the increased expenditure on on-going research and development projects. As a percentage o
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
2. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
3. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
4. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
7. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
8. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
9. Simceres Diosmectite API Passes EU-GMP Inspection
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
11. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 3, 2015  VA North Texas Health Care ... of vBloc, a technology-based, scientifically advanced weight loss ... implant called the Maestro® Rechargeable System that intermittently ... messages involving food intake and processing between the ... and customizable to meet the needs of a ...
(Date:6/3/2015)... , June 3, 2015  SurgiQuest®, Inc. ... access technologies for minimally invasive surgery (MIS) announced ... System in over 250,000 procedures.  Adoption has risen ... over last year, driven by the company,s expansion ... well as geographic expansion to over 45 countries.   ...
(Date:6/3/2015)... DUBLIN , June 02, 2015 ... the addition of the "Global Neurodegenerative Diseases ... The global neurodegenerative diseases market to grow ... 2014-2019. This report covers the present ... neurodegenerative diseases market for the period 2015-2019. To ...
Breaking Medicine Technology:VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3Rapid Procedure Growth With SurgiQuest's AirSeal System 2Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2
(Date:6/3/2015)... BC (PRWEB) June 03, 2015 Vancouver ... announced that the firm will now handle personal injury ... Greater Vancouver on the rise, more and more people ... year bus accidents cause needless suffering, serious injury and ... a result of a bus accident in BC you ...
(Date:6/3/2015)... 03, 2015 VeoMed and Decker ... online and mobile access to premier Continuing Medical ... of Certification (MOC) activities. , ... courses to Decker’s extensive lists of physicians, residents, ... access to VeoMed’s premier online and live-streamed courses. ...
(Date:6/3/2015)... June 03, 2015 Visual BI ... solutions, today announced the launch of the second ... for SAP® BusinessObjects™ Design Studio. The Design Studio ... capabilities and advanced functionalities into their dashboarding projects. ... suite, Visual BI is adding key components for ...
(Date:6/3/2015)... June 03, 2015 According to an ... police officers intercepted fake oxycodone pills which actually contained ... doctored to look legitimate, and even sported the “A/215” ... warning those consuming 30 mg oxycodone to be exceptionally ... online or buy them illegally on the street. Fentanyl ...
(Date:6/3/2015)... These are challenging and unpredictable times ... number of digital-first business are rewriting the rules for ... serious need for traditional businesses to take on a ... deliver their services. On top of this there ... technology start-ups, to bring new innovation and approaches to ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2
... Study finds evidence of cold viruses in majority of kids ... -- Researchers have discovered a link between infection with enteroviruses ... type 1 diabetes in children. , It,s not clear how ... the existence of the virus could be a biomarker for ...
... Fears about beta blockers making COPD worse are unfounded, ... Medical tradition says that the beta blockers used to ... also have severe lung disease, but a new Dutch ... of more than 2,200 people with chronic obstructive pulmonary ...
... measurable benefits, study found , MONDAY, May 24 (HealthDay News) ... drink intake could improve your blood pressure, researchers report. , ... blood pressure -- 1.8 points in systolic pressure, the higher ... diastolic pressure -- when intake was reduced by about a ...
... and other drug-resistant viruses may be thwarted by a potent, ... nanorods, report scientists at the University at Buffalo and the ... published in the current issue of the Proceedings of ... by UB and the CDC has the potential to usher ...
... ... San Antonio can access expert aftercare at BMI of Texas. , ... (PRWEB) May 24, 2010 -- The ... weight loss surgery procedures in Texas, today announced its participation in Allergan’s ...
... teeth into their senior design projects. This year, one ... Five Rice seniors have created a portable dental suction ... commonly used in dentists, offices to remove blood and ... that big systems cost a lot, more than dental ...
Cached Medicine News:Health News:Viral Infection Could Be Marker for Type 1 Diabetes 2Health News:Heart Drugs Safe for Lungs, Study Finds 2Health News:Heart Drugs Safe for Lungs, Study Finds 3Health News:Fewer Sugary Drinks, Less High Blood Pressure 2Health News:Fewer Sugary Drinks, Less High Blood Pressure 3Health News:To attack H1N1, other flu viruses, gold nanorods deliver potent payload 2Health News:BMI of Texas Selected to Participate in Lap-Band Total Care™ Out of Towner Network 2Health News:BMI of Texas Selected to Participate in Lap-Band Total Care™ Out of Towner Network 3Health News:Grin and bear it 2Health News:Grin and bear it 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: